睿智医药(300149) - 2023 Q1 - 季度财报(更新)

I. Key Financial Data 1. Key Accounting Data and Financial Indicators The company experienced a significant decline in Q1 2023, with operating revenue decreasing by 30.45% and net profit turning to a loss of RMB 25.15 million Key Financial Indicators for Q1 2023 | Indicator | Current Period | Prior Year Period | Year-over-Year Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue (RMB) | 268,658,644.91 | 386,301,922.70 | -30.45% | | Net Profit Attributable to Shareholders (RMB) | -25,145,108.24 | 9,470,996.67 | -365.50% | | Net Profit Attributable to Shareholders (Excluding Non-recurring Items) (RMB) | -29,246,265.24 | 8,185,287.55 | -457.30% | | Net Cash Flow from Operating Activities (RMB) | -20,654,400.58 | 34,944,776.30 | -159.11% | | Basic Earnings Per Share (RMB/share) | -0.05 | 0.02 | -350.00% | | Weighted Average Return on Net Assets | -1.08% | 0.48% | -1.56% | Key Balance Sheet Indicators as of Q1 2023 End | Indicator | End of Current Period | End of Prior Year | Change from Prior Year End (%) | | :--- | :--- | :--- | :--- | | Total Assets (RMB) | 3,470,187,037.38 | 3,807,937,141.71 | -8.87% | | Equity Attributable to Shareholders (RMB) | 2,315,016,426.62 | 2,345,576,001.31 | -1.30% | 2. Non-recurring Gains and Losses Items and Amounts Non-recurring gains and losses totaled RMB 4.10 million, primarily from investment income and government grants Non-recurring Gains and Losses Items for Q1 2023 | Item | Amount for Current Period (RMB) | | :--- | :--- | | Government grants recognized in current profit or loss | 1,903,168.29 | | Investment income from long-term equity investments measured at fair value | 2,702,193.86 | | Other non-operating income and expenses | 121,529.93 | | Less: Income tax impact | 625,708.37 | | Less: Impact on minority interests (after tax) | 26.71 | | Total | 4,101,157.00 | 3. Changes and Reasons for Key Accounting Data and Financial Indicators Significant changes in financial indicators include a 54.95% decrease in cash, a 134.94% increase in construction in progress, a 30.45% drop in revenue, and a 645.26% surge in investment income - Significant Balance Sheet Item Changes: - Cash and cash equivalents decreased by 54.95%, primarily due to repayment of bank loans and prepayment of 2022 corporate income tax[4][5] - Construction in progress increased by 134.94%, mainly due to increased investment in the Lingang office building construction[4][5] - Salaries payable decreased by 54.29%, primarily due to payment of year-end bonuses from the previous year[4][5] - Non-current liabilities due within one year decreased by 47.53%, mainly due to repayment of bank loans[4][5] - Significant Income Statement Item Changes: - Operating revenue decreased by 30.45%, primarily due to the disposal of a subsidiary[5] - Selling expenses decreased by 44.00%, also mainly affected by the disposal of a subsidiary[5] - Investment income significantly increased by 645.26%, primarily due to increased investment income under the equity method for long-term equity investments[5] - Significant Cash Flow Statement Item Changes: - Net cash flow from operating activities decreased by 159.11%, primarily due to prepayment of 2022 corporate income tax[5] - Net cash flow from investing activities increased by 245.13%; excluding the impact of recovering time deposits, it actually decreased by 209% year-over-year, mainly due to increased payments for Lingang projects and fund contributions in the current period[5] - Net cash flow from financing activities decreased by 182.31%, primarily due to repayment of bank loans and interest in the current reporting period[5] II. Shareholder Information 1. Total Number of Common Shareholders, Preferred Shareholders with Restored Voting Rights, and Top Ten Shareholders' Holdings As of the reporting period end, the company had 27,692 common shareholders, with the top three holding 13.69%, 10.24%, and 6.88% respectively - Total common shareholders at the end of the reporting period were 27,692[6] Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Nature | Holding Percentage (%) | Number of Shares | | :--- | :--- | :--- | :--- | | Beihai Baben Venture Capital Co., Ltd. | Domestic Non-State-Owned Legal Person | 13.69% | 68,441,800.00 | | Hangzhou Cixuan Liangjia Investment Management Partnership (Limited Partnership) | Domestic Non-State-Owned Legal Person | 10.24% | 51,185,660.00 | | Shanghai Ruiyun Enterprise Management Center (Limited Partnership) | Domestic Non-State-Owned Legal Person | 6.88% | 34,380,629.00 | | Hong Kong Securities Clearing Company Limited | Overseas Legal Person | 5.38% | 26,895,270.00 | | MEGA STAR CENTRE LIMITED | Overseas Legal Person | 4.54% | 22,711,333.00 | | Industrial and Commercial Bank of China Limited - Rongtong Health Industry Flexible Allocation Mixed Securities Investment Fund | Other | 3.86% | 19,300,000.00 | | Shaoguan Baotao Enterprise Management Co., Ltd. | Domestic Non-State-Owned Legal Person | 2.94% | 14,716,900.00 | | Zeng Xianjing | Domestic Natural Person | 2.55% | 12,755,275.00 | | Hunan Jiaquan Business Co., Ltd. | Domestic Non-State-Owned Legal Person | 2.44% | 12,199,518.00 | | Zhang Daocai | Domestic Natural Person | 1.58% | 7,908,340.00 | - Shareholder Relationship Explanation: Shareholder Zeng Xianjing is the actual controller of the largest shareholder, Beihai Baben Venture Capital Co., Ltd. The company is unaware of any other related party relationships or concerted actions among other shareholders[7] 2. Total Number of Preferred Shareholders and Top 10 Preferred Shareholders' Holdings The company had no preferred shareholders during the reporting period - The company has no preferred shareholder holdings[8] 3. Restricted Share Changes Restricted shares increased from 6,900 to 9,200 due to a shareholder's departure, with a proposed lifting date of July 18, 2023 Restricted Share Change Details | Shareholder Name | Restricted Shares at Beginning of Period | Shares Added This Period | Restricted Shares at End of Period | Reason for Restriction | Proposed Lifting Date | | :--- | :--- | :--- | :--- | :--- | :--- | | Xia Danying | 6,900.00 | 2,300.00 | 9,200.00 | Shares fully locked due to departure within 6 months of the reporting period | July 18, 2023 | III. Other Significant Matters The company had no other significant matters requiring disclosure during the reporting period - The company had no other significant matters in this reporting period[9] IV. Quarterly Financial Statements 1. Financial Statements 1. Consolidated Balance Sheet As of March 31, 2023, total assets were RMB 3.47 billion (down 8.87%), total liabilities RMB 1.13 billion (down 21.36%), and equity RMB 2.32 billion (down 1.30%) Key Balance Sheet Items (Unit: RMB) | Item | Period-End Balance | Year-Beginning Balance | | :--- | :--- | :--- | | Total Assets | 3,470,187,037.38 | 3,807,937,141.71 | | Cash and Cash Equivalents | 343,159,149.37 | 761,664,274.51 | | Construction in Progress | 151,262,575.86 | 64,384,084.50 | | Total Liabilities | 1,130,773,989.50 | 1,437,935,834.66 | | Short-term Borrowings | 95,022,611.08 | 115,022,611.12 | | Long-term Borrowings | 19,281,110.07 | 177,209,980.14 | | Total Equity Attributable to Parent Company Owners | 2,315,016,426.62 | 2,345,576,001.31 | 2. Consolidated Income Statement Q1 2023 operating revenue decreased by 30.45% to RMB 269 million, resulting in an operating loss of RMB 28.41 million and a net loss attributable to parent company owners of RMB 25.15 million Key Income Statement Items (Unit: RMB) | Item | Amount for Current Period | Amount for Prior Period | | :--- | :--- | :--- | | Total Operating Revenue | 268,658,644.91 | 386,301,922.70 | | Total Operating Costs | 300,284,445.11 | 368,984,885.99 | | Including: Operating Costs | 192,281,330.81 | 233,431,931.86 | | Operating Profit | -28,408,497.49 | 11,449,336.64 | | Total Profit | -28,286,967.56 | 11,452,290.01 | | Net Profit | -25,173,792.72 | 9,416,742.22 | | Net Profit Attributable to Parent Company Owners | -25,145,108.24 | 9,470,996.67 | 3. Consolidated Cash Flow Statement Net cash and cash equivalents decreased by RMB 246 million, with operating cash flow at -RMB 20.65 million, investing cash flow at RMB 55.63 million, and financing cash flow at -RMB 270 million Key Cash Flow Statement Items (Unit: RMB) | Item | Amount for Current Period | Amount for Prior Period | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -20,654,400.58 | 34,944,776.30 | | Net Cash Flow from Investing Activities | 55,629,297.92 | -38,329,695.69 | | Net Cash Flow from Financing Activities | -269,984,196.03 | -95,633,226.13 | | Effect of Exchange Rate Changes on Cash and Cash Equivalents | -11,069,197.38 | -392,232.43 | | Net Increase/Decrease in Cash and Cash Equivalents | -246,078,496.07 | -99,410,377.95 | 2. Audit Report The company's Q1 2023 report was unaudited - The first quarter report was unaudited[17]